Madrigal Pharmaceuticals MDGL Earnings Call Transcripts

NASDAQ MDGL
$432.60 -0.19 (-0.04%)
At close: Nov 10, 2026 · 4:00 PM EST
3 earnings calls on file for Madrigal Pharmaceuticals, from Q4 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Madrigal Pharmaceuticals Q3 2026 Earnings Call

Nov 3, 2026 9,301 words · 40 min read
  • Tina VenturaChief Investor Relations Officer
  • Bill SiboldChief Executive Officer
  • Dave SoergelChief Medical Officer
  • Mardi DierChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Madrigal Pharmaceuticals Earnings Call Transcripts

Calls3
LatestNov 3, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 3 Madrigal Pharmaceuticals transcripts Register to get access to Madrigal Pharmaceuticals’s earnings call transcripts.